Chinese AI drug researcher XtalPi expects to turn first annual profit on 193% revenue jump

Chinese artificial intelligence-powered drug researcher XtalPi Holdings said it expects to turn its first annual profit on the back of strong revenue growth, according to a corporate filing. The Shenzhen-based company projected a swing to a net profit of at least 100 million yuan (US$14.5 million) in 2025 from a net loss of around 1.5 billion yuan in 2024, notching its first full-year profit, according to a filing with the Hong Kong stock exchange on Tuesday. XtalPi attributed the earnings bo...

By Ben Jiang